Assessing the Benefits of Robotic and Laparoscopic Surgery for Mid and Low Rectal Cancer in Patients: The Charlson Comorbidity Index (CCI)

Daorong Wang1 site in 1 country505 target enrollmentJanuary 1, 2019

ConditionsRobotic Laparoscopic Anterior Resection for Rectal Cancer

Overview

Phase: N/A
Intervention: Not specified
Conditions: Robotic
Sponsor: Daorong Wang
Enrollment: 505
Locations: 1
Primary Endpoint: postoperative recurrence rate
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This retrospective study collected participants who underwent robotic or laparoscopic anterior resection for rectal cancer at the North People's Hospital in Jiangsu from January 2019 to January 2023.

Registry

clinicaltrials.gov

Start Date

January 1, 2019

End Date

January 3, 2024

Last Updated

2 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Daorong Wang

Responsible Party

Sponsor Investigator

Principal Investigator

Daorong Wang

Northern Jiangsu People's Hospital

Eligibility Criteria

Inclusion Criteria

•The criteria include: (1) pathology of low rectal cancer (within 10 cm from the anal margin); (2) access to comprehensive pathological and computed tomography (CT) data; (3) completeness of clinical data.